Goodwin advised Flagship Pioneering on the matter. Hogan Lovells acted for Omega Therapeutics, Inc. Novo Nordisk, Omega Therapeutics, Inc. (Nasdaq: OMGA) and Cellarity Inc. announced that Novo Nordisk...
Novo Nordisk’s Research Collaborations with Omega Therapeutics and Cellarity
PTC’s $1.46 Billion Acquisition of ServiceMax
Goodwin Procter advised PTC on the deal, Ropes & Gray represented ServiceMax, Latham & Watkins represented Centerview Partners. PTC (NASDAQ: PTC) signed its definitive agreement to acquire...
Landmark Bio’s Opening of State-of-the-art full-spectrum Development
Goodwin Procter advised Landmark Bio™ on the deal. Landmark Bio™ announced the opening of its state-of-the-art full-spectrum development and biomanufacturing facility in Watertown, Massachusetts. The 44,000 square-foot...
Walgreens Boots Alliance’s US$1.37 Billion Acquisition of Shields Health Solutions
Sidley represented Walgreens Boots Alliance, Ropes & Gray advised Welsh, Carson, Anderson & Stowe, while Goodwin Procter and K&L Gates advised Shields on the deal. Walgreens...
KVH Industries’ Asset Purchase Agreement with EMCORE Corporation
Goodwin Procter advised KVH Industries on the deal while Pillsbury advised EMCORE Corporation. KVH Industries, Inc. (NASDAQ: KVHI) announced its asset purchase agreement with EMCORE Corporation....
OPKO Health’s Acquisition of ModeX Therapeutics
Goodwin advised ModeX Therapeutics, Inc. on the deal while Greenberg Traurig represented OPKO Health Inc. ModeX Therapeutics, Inc. announced its sale to OPKO Health, Inc. (NASDAQ: OPK)...
GeneWerk’s Merger with Protagen Protein Services
Goodwin Procter advised GeneWerk on the deal. GeneWerk announced its merger with Protagen Protein Services. GeneWerk, an Ampersand portfolio company, is a cell and gene therapy testing...
2U’s $800 Million Acquisition of edX
Paul Hastings advised 2U, Inc. on the deal while Goodwin Procter represented edX. 2U, Inc., a global leader in education technology, announced a definitive agreement to acquire...
Datavant Inc.’s Merger with Ciox Health LLC
Sidley Austin advised Sixth Street and Goldman Sachs on the deal while Goodwin Procter LLP represented Datavant. Ropes & Gray represented New Mountain Capital and its...
Cerevel Therapeutics’ $125 Million Non-dilutive Financing Transaction for Tavapadon
Goodwin Procter LLP advised Cerevel Therapeutics on the deal. Ropes & Gray represented Bain Capital, while Wyrick Robbins Yates & Ponton LLP acted as legal counsel...